title: Deep brain stimulation: indications and evidence.
abstract: Deep brain stimulation is a minimally invasive targeted neurosurgical intervention that enables structures deep in the brain to be stimulated electrically by an implanted pacemaker. It has become the treatment of choice for Parkinson's disease, refractory to, or complicated by, drug therapy. Its efficacy has been demonstrated robustly by randomized, controlled clinical trials, with multiple novel brain targets having been discovered in the last 20 years. Multifarious clinical indications for deep brain stimulation now exist, including dystonia and tremor in movement disorders; depression, obsessive-compulsive disorder and Tourette's syndrome in psychiatry; epilepsy, cluster headache and chronic pain, including pain from stroke, amputation, trigeminal neuralgia and multiple sclerosis. Current research argues for novel indications, including hypertension and orthostatic hypotension. The development, principles, indications and effectiveness of the technique are reviewed here. While deep brain stimulation is a standard and widely accepted treatment for Parkinson's disease after 20 years of experience, in chronic pain it remains restricted to a handful of experienced, specialist centers willing to publish outcomes despite its use for over 50 years. Reasons are reviewed and novel approaches to appraising clinical evidence in functional neurosurgery are suggested.
authors.affiliation: Oxford Functional Neurosurgery, Nuffield Department of Surgery and Department of Neurological Surgery, The West Wing, The John Radcliffe Hospital, Oxford, OX3 9DU, UK. eacp@eacp.co.uk
authors.forename: Erlick A C
authors.initials: EA
authors.lastname: Pereira
authors.forename: Alexander L
authors.initials: AL
authors.lastname: Green
authors.forename: Dipankar
authors.initials: D
authors.lastname: Nandi
authors.forename: Tipu Z
authors.initials: TZ
authors.lastname: Aziz
mesh_terms: D002493:Central Nervous System Diseases / Q000628:therapy*; D003362:Cost-Benefit Analysis; D046690:Deep Brain Stimulation / Q000009:adverse effects / Q000191:economics / Q000295:instrumentation; D006801:Humans; D016896:Treatment Outcome